David P Nicolau Selected Research

Blister (Bulla)

11/2015	Antibiotic Tissue Penetration in Diabetic Foot Infections A Review of the Microdialysis Literature and Needs for Future Research.
9/2007	Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
2/2006	Tissue penetration of telavancin after intravenous administration in healthy subjects.
4/2005	Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations.
1/2005	Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
1/2005	Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
7/2003	Production and resolution of cantharidin-induced inflammatory blisters.
5/2003	Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David P Nicolau Research Topics

Disease

214	Infections 03/2024 - 01/2002
57	Pneumonia (Pneumonitis) 12/2023 - 05/2002
34	Body Weight (Weight, Body) 10/2021 - 10/2002
30	Critical Illness (Critically Ill) 04/2024 - 11/2006
15	Ventilator-Associated Pneumonia 12/2023 - 02/2009
15	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 04/2004
15	Intraabdominal Infections 12/2020 - 08/2005
14	Healthcare-Associated Pneumonia 01/2023 - 05/2002
14	Bacteremia 01/2022 - 03/2007
12	Sepsis (Septicemia) 10/2022 - 07/2005
12	Respiratory Tract Infections (Respiratory Tract Infection) 09/2022 - 02/2004
12	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2015
9	Wounds and Injuries (Trauma) 01/2022 - 11/2008
9	Soft Tissue Infections 05/2021 - 05/2003
8	Diabetic Foot 12/2022 - 01/2010
8	Blister (Bulla) 11/2015 - 05/2003
7	Cross Infection (Nosocomial Infection) 12/2023 - 08/2004
7	Bacterial Pneumonia 04/2023 - 09/2011
7	Communicable Diseases (Infectious Diseases) 09/2022 - 01/2008
6	Pneumococcal Pneumonia 11/2021 - 05/2002
5	Meningitis 01/2022 - 01/2006
5	Bacterial Infections (Bacterial Infection) 04/2021 - 02/2004
5	Surgical Wound Infection 01/2019 - 08/2009
5	Pseudomonas Infections 01/2018 - 05/2002
4	AIDS-Related Complex (ARC) 10/2022 - 12/2019
4	Wound Infection (Wound Infections) 01/2022 - 01/2005
4	Osteomyelitis 06/2021 - 05/2016
4	Peritonitis 05/2007 - 01/2005
3	Endocarditis 01/2022 - 03/2007
3	Overweight 12/2020 - 09/2015
3	Febrile Neutropenia 12/2017 - 10/2012
3	Coinfection 06/2016 - 08/2009
3	Clostridium Infections 04/2016 - 08/2015

Drug/Important Bio-Agent (IBA)

100	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 12/2002
45	Meropenem (Merrem)FDA LinkGeneric 01/2024 - 05/2003
32	Cefepime (Maxipime)FDA LinkGeneric 12/2023 - 06/2004
29	Carbapenems (Carbapenem Antibiotics)IBA 08/2023 - 08/2004
27	Vancomycin FDA LinkGeneric 11/2021 - 11/2006
22	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2021 - 04/2002
21	tazobactam drug combination ceftolozaneIBA 04/2021 - 09/2015
20	LactamsIBA 03/2023 - 02/2014
19	CefiderocolIBA 08/2023 - 11/2017
17	Tigecycline (Tygacil)FDA Link 10/2022 - 01/2005
16	Ceftazidime (Fortum)FDA LinkGeneric 01/2024 - 06/2004
14	CreatinineIBA 03/2024 - 03/2004
13	Imipenem FDA Link 03/2024 - 10/2005
13	ceftazidime drug combination avibactamIBA 01/2024 - 12/2012
13	Daptomycin FDA Link 01/2021 - 09/2003
12	Levofloxacin (Levaquin)FDA Link 12/2021 - 04/2004
11	Cefazolin (Ancef)FDA LinkGeneric 05/2021 - 02/2012
11	Linezolid (Zyvox)FDA Link 01/2021 - 01/2005
11	Doripenem FDA Link 01/2016 - 07/2008
10	Tazobactam FDA LinkGeneric 12/2021 - 05/2002
9	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023 - 12/2002
9	Ertapenem (Invanz)FDA Link 01/2022 - 01/2005
9	Anti-Infective Agents (Microbicides)IBA 10/2021 - 01/2008
9	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019 - 12/2006
9	beta-LactamsIBA 01/2018 - 01/2005
8	carbapenemaseIBA 01/2024 - 01/2014
8	Amikacin (A.M.K)FDA LinkGeneric 01/2023 - 03/2016
8	avibactamIBA 01/2020 - 07/2011
8	Colistin (Coly-Mycin)FDA Link 09/2019 - 01/2006
8	Ceftaroline FDA Link 12/2014 - 07/2011
7	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 03/2024 - 01/2005
7	relebactamIBA 03/2024 - 01/2019
7	Serine (L-Serine)FDA Link 01/2024 - 01/2019
6	ceftolozaneIBA 01/2022 - 05/2016
6	cefepime-zidebactamIBA 12/2021 - 11/2018
6	telavancin FDA Link 11/2021 - 02/2006
6	eravacyclineIBA 12/2020 - 01/2014
6	AminoglycosidesIBA 10/2019 - 01/2006
6	Methicillin (Metin)FDA Link 01/2018 - 03/2009
6	Clarithromycin (Biaxin)FDA LinkGeneric 12/2005 - 05/2002
5	SiderophoresIBA 07/2023 - 02/2018
5	tedizolidIBA 01/2019 - 05/2012
5	oritavancinIBA 10/2016 - 01/2005
5	FluoroquinolonesIBA 06/2016 - 04/2004
5	beta-Lactamases (beta-Lactamase)IBA 01/2008 - 03/2003
4	meropenem and vaborbactamIBA 01/2024 - 01/2021
4	taniborbactamIBA 01/2023 - 12/2020
4	Ceftibuten (Cedax)FDA Link 12/2022 - 01/2019
4	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022 - 03/2004
4	Penicillins (Penicillin)FDA Link 11/2021 - 04/2004
4	plazomicinIBA 10/2019 - 01/2018
4	dalbavancinIBA 10/2016 - 01/2005
3	Polymyxins (Polymyxin)IBA 01/2023 - 01/2006
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2021
3	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 05/2009
3	nacubactamIBA 02/2020 - 01/2018
3	Piperacillin FDA LinkGeneric 01/2019 - 05/2002
3	LipoglycopeptidesIBA 10/2016 - 03/2007

Therapy/Procedure

59	Therapeutics 12/2023 - 05/2002
10	Length of Stay 01/2018 - 06/2004
9	Catheters 01/2022 - 05/2007
7	Mechanical Ventilators (Ventilator) 04/2023 - 09/2011
6	Continuous Renal Replacement Therapy 04/2024 - 12/2015
3	Extracorporeal Membrane Oxygenation 03/2024 - 07/2022
3	Renal Dialysis (Hemodialysis) 06/2021 - 11/2011
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2005
3	Critical Care (Surgical Intensive Care) 01/2017 - 02/2009